Home › Funds › Mirador Capital Partners LP › IOVA

Mirador Capital Partners LP position in IOVA

IOVANCE BIOTHERAPEUTICS INC · Health Care

Mirador Capital Partners LP reported holding 1,095,740 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$16.2M, representing 1.89% of its reported portfolio and ranking #16 among its reported holdings. Mirador Capital Partners LP has disclosed IOVA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)1.10M sh
Reported value held$16.24M
Portfolio Weight1.89%
First reportedQ3 2025
Last changeAdd
Updated2026-10-10

Last updated: 2026-10-10 · Source: SEC EDGAR Form 13F-HR

How Mirador Capital Partners LP's IOVA position evolved

Mirador Capital Partners LP first disclosed a stake in IOVA in Q3 2025 at 515,025 shares (US$1.1M). The position peaked in Q3 2026 at 1,095,740 shares, worth US$16.2M. Across 5 filings, Mirador Capital Partners LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,095,740 shares valued at US$16.2M — an increase of 15,452 shares quarter over quarter.. Notable position changes include a 101% increase in Q4 2025 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 515.02K $1.12M New
Q4 2025 1.03M $2.82M Add
Q1 2026 1.07M $3.77M Add
Q2 2026 1.08M $4.49M Add
Q3 2026 1.10M $16.24M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IOVA and 13F data

IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IOVA

All IOVA fund holders →

FAQ

How long has Mirador Capital Partners LP held IOVA?

Mirador Capital Partners LP has disclosed IOVA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Mirador Capital Partners LP's current position in IOVA?

As of Q3 2026, Mirador Capital Partners LP holds 1.10M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $16.24M, representing 1.89% of its reported portfolio and ranking #16.

Has Mirador Capital Partners LP been buying or selling IOVA?

In the latest 13F filing (Q3 2026), Mirador Capital Partners LP increased its position in IOVA. The position peaked in Q3 2026 at 1.10M shares.

Which other funds hold IOVA?

Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.